InnoCare (诺诚健华) Pre-IPO: A Decent Team but Short of Clinical Stage Candidates
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. We will discuss...
727 Views
𝛼SK or SearchENTITY
InnoCare Pharma (9969 HK)
InnoCare Pharma (9969 HK)
120
Analysis
Health Care • China
InnoCare Pharma is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for cancer and autoimmune diseases. Its pipeline includes key products like orelabrutinib, tafasitamab, and ICP-332. The company was co-founded in 2015 and is headquartered in Beijing, China.
morex